DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL OF FLEXIBLE DOSE DIVALPROEX SODIUM

灵活剂量双丙戊酸钠的双盲、安慰剂对照试验

• 批准号: 7375359
• 负责人: Joseph C Blader
• 金额: $ 2.93万
• 依托单位: STATE UNIVERSITY NEW YORK STONY BROOK
• 依托单位国家: 美国
• 财政年份: 2005
• 资助国家: 美国
• 起止时间: 2005-12-01 至 2006-11-30
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/7375359
• 关键词: DOUBLE; BLIND; PLACEBO; CONTROLLED; TRIAL

This subproject is one of many research subprojects utilizing the resources provided by a Center grant funded by NIH/NCRR. The subproject and investigator (PI) may have received primary funding from another NIH source, and thus could be represented in other CRISP entries. The institution listed is for the Center, which is not necessarily the institution for the investigator. The purpose of this study is to investigate a medication treatment strategy for children who have both ADHD and other difficulties with behavior and self control particularly aggression. Medication for ADHD can help both the main symptoms of ADHD ( inattention,restlessness,inpulsiveness) and conduct problem behaviors (trouble following directions and rules, aggressiveness, anger control difficulties,etc.).

本子项目是利用由NIH/NCRR资助的中心赠款提供的资源的众多研究子项目之一。子项目和研究者（PI）可能已经从另一个NIH来源获得了主要资金，因此可以在其他CRISP条目中表示。列出的机构是中心的，不一定是研究者的机构。本研究的目的是为患有多动症和其他行为和自我控制困难的儿童（尤其是攻击性）研究一种药物治疗策略。ADHD的药物治疗可以帮助ADHD的主要症状（注意力不集中、烦躁不安、冲动）和行为问题行为（难以遵守指示和规则、攻击性、愤怒控制困难等）。